| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/19/2000 | US6121276 Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 09/19/2000 | US6120799 For treatment and diagnosisdiseases and abnormalities such as cancer, wound healing, and chronic inflammatory diseases |
| 09/19/2000 | US6120768 Dota-biotin derivatives |
| 09/19/2000 | US6120751 Charged lipids and uses for the same |
| 09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | WO2000053170A1 Means for diagnosing and treating carcinoma |
| 09/14/2000 | DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation |
| 09/14/2000 | CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/13/2000 | EP1034796A1 Mri contrast media recognizing minor environmental changes |
| 09/13/2000 | CN1266538A Retentate chromatography and protein chip arrays applications in biology and medicine |
| 09/13/2000 | CN1266537A Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 09/12/2000 | US6117858 For specific delivery of biologically active substances to achieve lower doses and for improved efficacy with drugs such as oligonucleotides and polynucleotides with problems in achieving therapeutic concentrations at targeted organs |
| 09/12/2000 | US6117414 Administering hydrophilic polymer covalently bonded to biocompatible lipid filled with perfluorocarbon of sulfur hexafluoride gas |
| 09/12/2000 | US6117412 Administering bismuth compound containing additional heavy atom as contrast enhancer; x-rays, magnetic resonance, ultrasound, and scintigraphic imaging |
| 09/08/2000 | WO2000052466A2 Measurement of tear fluorescein clearance |
| 09/08/2000 | WO2000051646A2 Assay for emetic activity |
| 09/08/2000 | WO1999049019A8 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 09/08/2000 | CA2362305A1 Assay for emetic activity |
| 09/06/2000 | EP1033137A1 Diagnostics for complications of diabetes or renal insufficiency |
| 09/06/2000 | EP1032591A1 NOVEL pth |
| 09/06/2000 | EP1032430A2 Magnetic resonance imaging agents for the detection of physiological agents |
| 09/06/2000 | EP1032321A4 Method for improved selectivity in photo-activation and detection of molecular diagnostic agents |
| 09/06/2000 | EP1032321A1 Method for improved selectivity in photo-activation and detection of molecular diagnostic agents |
| 09/06/2000 | EP1032304A1 Reagent for tumor therapy and/or imaging |
| 09/06/2000 | EP0504388B1 Varicella-zoster virus antigen |
| 09/06/2000 | CN1265599A Cloning using donor nuclei from non-serum starved, differentiated cells |
| 09/06/2000 | CN1056162C Polyaminated ligands and metal complexes thereof |
| 09/05/2000 | US6114382 Diagnosing inflammatory bowel disease(ibd) by detecting presence of microsporidia; and administering a drug such as teclozan to kill living microsporidia in the patient's gastrointestinal tract; making an animal model of ibd |
| 09/05/2000 | US6114350 Cyanine dyes and synthesis methods thereof |
| 09/05/2000 | US6114304 Administering an amylin agonist such as pramlintide or pramlintide acetate; reducing gastric motility or delaying gastric emptying |
| 09/05/2000 | US6114175 Amyloid-binding compounds which are non-azo derivatives of chrysamine g to determine degree of brain deposits quantitatively characterized by amyloidosis; down's syndrome; prevent cell degeneration; radioactive imaging |
| 09/05/2000 | US6114038 Functionalized nanocrystals and their use in detection systems |
| 09/05/2000 | US6113880 Angiograpy and lymphography diagnostic agents; complexing |
| 09/05/2000 | US6113875 Isotope-labelled urea and acid; ulcers |
| 09/05/2000 | US6113570 Method of removing thrombosis in fistulae |
| 09/05/2000 | CA2188662C New method of treatment |
| 09/05/2000 | CA2082928C Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
| 09/05/2000 | CA2047685C Purified insulin mediators and purification process for same |
| 09/05/2000 | CA2039399C Dual functioning excipient for metal chelate contrast agents |
| 08/31/2000 | WO2000050892A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage |
| 08/31/2000 | WO2000050093A1 Method of measuring physiological function |
| 08/31/2000 | WO2000019823A9 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof |
| 08/31/2000 | WO2000018949A9 Delivery of phosphoinositide polyphosphates into cells |
| 08/31/2000 | CA2362585A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage |
| 08/31/2000 | CA2360421A1 Method of measuring physiological function |
| 08/30/2000 | EP1031354A2 Polymeric MRI Contrast agents |
| 08/30/2000 | EP1030926A2 Transgenic models of inflammatory disease |
| 08/30/2000 | EP1030594A1 Apparatus for fluid administration |
| 08/30/2000 | EP0671946B1 Immunoreactive peptides from epstein-barr virus |
| 08/30/2000 | CN1265045A Process for selection of particles of preselected size from particulate pharmaceutical product |
| 08/30/2000 | CN1265039A Use of texaphyrin in prepn. of medicament for use in ocular diagnosis and therapy |
| 08/30/2000 | CN1264600A Definition medium and its application |
| 08/30/2000 | CN1055865C X-ray colon special double-contrast contrast medium |
| 08/30/2000 | CN1055864C Method of preparing contract media |
| 08/29/2000 | US6110679 Generating compressed nucleus material by incubation of cells with enzyme inhibitors |
| 08/29/2000 | US6110459 Grafting of myocardium tissues |
| 08/29/2000 | US6110444 Dispersion free microbubbles of water insoluble gas |
| 08/29/2000 | US6110443 Dissolving in water and ultrasonic imaging and microbubble with surfactants of phospholipid and stabilizers |
| 08/24/2000 | WO2000048990A1 Phthalamide-lanthanide complexes for use as luminescent markers |
| 08/24/2000 | WO1999066831A3 Utilization of 5-aminolevulinic acid or a derivative thereof for photodynamic diagnosis or photodynamic therapy of diseases of the parodontium and teeth |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/23/2000 | EP1029039A1 Non-transgenic animal model of alzheimer's disease |
| 08/23/2000 | EP1028991A1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 08/23/2000 | EP1028978A2 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 08/23/2000 | EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 08/23/2000 | EP1028941A2 Compounds for the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 08/23/2000 | EP1028758A1 Methods for treating prostate tumors using radioactive compositions |
| 08/23/2000 | EP1028757A1 Radioactive embolizing compositions |
| 08/23/2000 | CN1264429A Metastasis models using green fluorescent protein (GFP) as marker |
| 08/23/2000 | CN1055641C Method of enhancing mental function |
| 08/22/2000 | US6108574 Overhauser enhanced magnetic resonance imaging technique (OMRI or PEDRI or ESREMRI) |
| 08/22/2000 | US6107544 Method for breeding disease resistance into plants |
| 08/22/2000 | US6107102 Therapeutic microdevices and methods of making and using same |
| 08/22/2000 | US6106866 In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites |
| 08/22/2000 | US6106807 Use of methylenemalondiester derivatives for the production of gas-containing microparticles for ultrasound diagnosis, as well as media that contain said particles |
| 08/22/2000 | US6106806 Microbubble-containing contrast agents having a non-proteinaceous crosslinked or polymerised amphiphilic shell |
| 08/22/2000 | US6106805 Diagnostic composition containing an LH-RH antagonist for hysteroscopy |
| 08/22/2000 | US6106473 Echogenic coatings |
| 08/17/2000 | WO2000047549A1 Preparation of iodixanol |
| 08/17/2000 | WO2000047239A1 Diagnostic agent comprising nicotine |
| 08/17/2000 | WO2000047111A1 Ph sensitive mri contrast agents |
| 08/17/2000 | WO2000015231A9 Adenosine a3 receptor modulators |
| 08/16/2000 | EP1027080A1 Method for detection of fibrin clots |
| 08/16/2000 | EP1027079A1 Enhancement of delivery of radioimaging and radioprotective agents |
| 08/16/2000 | EP1027077A1 Magnetic resonance imaging agents for the delivery of therapeutic agents |
| 08/16/2000 | EP1027035A2 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 08/16/2000 | EP0799045B1 Treatment of hyperexcited nerve cell functions |
| 08/16/2000 | EP0707474B1 Medical use of organic aerogels and biodegradable organic aerogels |
| 08/16/2000 | EP0703790B1 Iodinated paramagnetic chelates, and their use as contrast agents |
| 08/16/2000 | CN1263474A Use of intravenous contrast agents and device for projection mammography |
| 08/16/2000 | CN1263449A Device for projection mammography |
| 08/16/2000 | CN1055414C Method for preparation of polymeric gas or air filled microballoons |
| 08/16/2000 | CN1055413C Method for preparing composition suitable for injecting into vivo-blood vessel and body cavity |
| 08/15/2000 | US6103751 Injecting a carotene conjugate of a photosensitizer selected from porphyrins, chlorins and bacteriochlorins into an animal at a desired dosage and detecting loactions of the concentrated uptake of the compound by spectroscopy |
| 08/15/2000 | US6103710 Glucocorticoid response elements |
| 08/15/2000 | US6103700 Fluoro labelled anthracyclinone and anthracycline derivatives |
| 08/15/2000 | US6103216 Hepatocyte-selective oil-in-water emulsion |
| 08/10/2000 | WO2000046343A2 Screening assay for antagonists of fgfr-mediated malignant cell transformation and tumor formation |